{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:02:02Z","timestamp":1776902522124,"version":"3.51.2"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jneuroim.2016.07.002","type":"journal-article","created":{"date-parts":[[2016,7,9]],"date-time":"2016-07-09T06:28:10Z","timestamp":1468045690000},"page":"58-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Thymus involvement in myasthenia gravis: Epidemiological and clinical impacts of different self-tolerance breakdown mechanisms"],"prefix":"10.1016","volume":"298","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5625-7900","authenticated-orcid":false,"given":"Arnon","family":"Karni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Asmail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian E.","family":"Drory","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hadar","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anat","family":"Kesler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2016.07.002_bb0005","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1056\/NEJM197412122912403","article-title":"The thymus in myasthenia gravis. Evidence for altered cell populations","volume":"291","author":"Abdou","year":"1974","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0010","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jaut.2013.12.001","article-title":"Genetic basis of autoimmune myasthenia gravis \u2014 a comprehensive review","volume":"52","author":"Avidan","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0015","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.autrev.2015.09.005","article-title":"Thymoma associated with autoimmune diseases: 85 cases and literature review","volume":"15","author":"Bernard","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0020","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jaut.2013.12.011","article-title":"Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms","volume":"52","author":"Berrih-Aknin","year":"2014","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0025","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1749-6632.1987.tb51282.x","article-title":"The role of the thymus in myasthenia gravis: immunohistological and immunological studies in 115 cases","volume":"505","author":"Berrih-Aknin","year":"1987","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0030","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.autrev.2013.03.011","article-title":"Ectopic germinal centers, BAFF and anti-B-cell therapy in myasthenia gravis","volume":"12","author":"Berrih-Aknin","year":"2013","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0035","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jaut.2014.01.003","article-title":"Diagnostic and clinical classification of autoimmune myasthenia","volume":"48-49","author":"Berrih-Aknin","year":"2014","journal-title":"J. Autoimmun"},{"issue":"Suppl. 2","key":"10.1016\/j.jneuroim.2016.07.002_bb0040","first-page":"57","article-title":"Morphological imaging of thymic disorders","volume":"31","author":"Camera","year":"1999","journal-title":"Ann Med."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0045","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1212\/WNL.0000000000000478","article-title":"Anti-agrin autoantibodies in myasthenia gravis","volume":"82","author":"Gasperi","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0050","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1196\/annals.1405.027","article-title":"Genetic factors in autoimmune myasthenia gravis","volume":"1132","author":"Giraud","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0055","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1749-6632.2012.06791.x","article-title":"Defects of immunoregulatory mechanisms in myasthenia gravis: role of IL-17","volume":"1274","author":"Gradolatto","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0060","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/ana.23691","article-title":"Risk for myasthenia gravis maps to a (151) Pro\u2013>Ala change in TNIP1 and to human leukocyte antigen-B*08","volume":"72","author":"Gregersen","year":"2012","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0065","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1111\/j.1749-6632.1987.tb51317.x","article-title":"The course of myasthenia gravis and therapies affecting outcome","volume":"505","author":"Grob","year":"1987","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0070","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1001\/archneurol.2009.235","article-title":"Multifocal paraneoplastic cortical encephalitis associated with myasthenia gravis and thymoma","volume":"66","author":"Hammoud","year":"2009","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0075","first-page":"268","article-title":"Pathogenesis of myasthenia gravis. Acetylcholine receptor-related antigenic determinants in tumor-free thymuses and thymic epithelial tumors","volume":"130","author":"Kirchner","year":"1988","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0080","doi-asserted-by":"crossref","first-page":"401","DOI":"10.3109\/08916930903563491","article-title":"Thymic remodeling associated with hyperplasia in myasthenia gravis","volume":"43","author":"Le Panse","year":"2010","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0085","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2169\/internalmedicine.47.0838","article-title":"Malignant thymoma associated with myasthenia gravis, Graves' disease, and SIADH","volume":"47","author":"Lee","year":"2008","journal-title":"Intern. Med."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0090","doi-asserted-by":"crossref","first-page":"893","DOI":"10.2353\/ajpath.2007.070240","article-title":"Myasthenia gravis thymus: complement vulnerability of epithelial and myoid cells, complement attack on them, and correlations with autoantibody status","volume":"171","author":"Leite","year":"2007","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/clin.1996.0001","article-title":"The thymus and the pathogenesis of myasthenia gravis","volume":"78","author":"Levinson","year":"1996","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0100","first-page":"215","article-title":"The intrathymic pathogenesis of myasthenia gravis","volume":"11","author":"Levinson","year":"2004","journal-title":"Clin. Dev. Immunol."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0105","doi-asserted-by":"crossref","first-page":"841","DOI":"10.4049\/jimmunol.0802046","article-title":"Prednisolone treatment induces tolerogenic dendritic cells and a regulatory milieu in myasthenia gravis patients","volume":"183","author":"Luther","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0110","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.expneurol.2015.02.010","article-title":"Thymoma related myasthenia gravis in humans and potential animal models","volume":"270","author":"Marx","year":"2015","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0115","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1172\/JCI119032","article-title":"Thymic hyperplasia in patients with Graves' disease. Identification of thyrotropin receptors in human thymus","volume":"98","author":"Murakami","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0120","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1749-6632.1987.tb51279.x","article-title":"Immunological heterogeneity and cellular mechanisms in myasthenia gravis","volume":"505","author":"Newsom-Davis","year":"1987","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0125","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1749-6632.1987.tb51328.x","article-title":"Thymectomy as primary therapy in myasthenia gravis","volume":"505","author":"Olanow","year":"1987","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0130","doi-asserted-by":"crossref","first-page":"e230","DOI":"10.1016\/j.crad.2014.01.005","article-title":"Imaging of thymus in myasthenia gravis: from thymic hyperplasia to thymic tumor","volume":"69","author":"Priola","year":"2014","journal-title":"Clin. Radiol."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0135","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jneuroim.2009.11.004","article-title":"Anti-acetylcholinesterase antibodies associate with ocular myasthenia gravis","volume":"218","author":"Provenzano","year":"2010","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0140","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1375\/twin.14.2.129","article-title":"Utilizing twins concordance rates to infer the predisposition to myasthenia gravis","volume":"14","author":"Ramanujam","year":"2011","journal-title":"Twin Res. Hum. Genet."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0145","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1001\/jamaneurol.2014.4103","article-title":"A genome-wide association study of myasthenia gravis","volume":"72","author":"Renton","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0150","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1084\/jem.156.6.1565","article-title":"Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocyte damage after adoptive transfer","volume":"156","author":"Sakaguchi","year":"1982","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0155","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2249.2007.03442.x","article-title":"Expression of autoimmune regulator gene (AIRE] and T regulatory cells in human thymomas","volume":"149","author":"Scarpino","year":"2007","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0160","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.410220205","article-title":"Acetylcholine receptors in human thymic myoid cells in situ: an immunohistological study","volume":"22","author":"Schluep","year":"1987","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0165","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/cmi.2010.74","article-title":"Thymoma and autoimmunity","volume":"8","author":"Shahar","year":"2011","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0170","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1146\/annurev.immunol.18.1.423","article-title":"Regulatory T cells in autoimmunity","volume":"18","author":"Shevach","year":"2000","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0175","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.4049\/jimmunol.167.4.1935","article-title":"Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis","volume":"167","author":"Sims","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0180","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.clim.2012.09.012","article-title":"Impaired regulatory function in circulating CD4+CD25highCD127low\/\u2212 T cells in patients with myasthenia gravis","volume":"145","author":"Thiruppathi","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0185","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1749-6632.2012.06840.x","article-title":"Functional defect in regulatory T cells in myasthenia gravis","volume":"1274","author":"Thiruppathi","year":"2012","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0190","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1136\/jnnp.48.12.1246","article-title":"Acetylcholine receptor antibody as a diagnostic test for myasthenia gravis: results in 153 validated cases and 2967 diagnostic assays","volume":"48","author":"Vincent","year":"1985","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0195","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0140-6736(78)90073-9","article-title":"In-vitro synthesis of anti acetylcholine-receptor antibody by thymic lymphocytes in myasthenia gravis","volume":"1","author":"Vincent","year":"1978","journal-title":"Lancet"},{"key":"10.1016\/j.jneuroim.2016.07.002_bb0200","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.imlet.2008.11.015","article-title":"The role of FoxP3 CD4 CD25hi Tregs in the pathogenesis of myasthenia gravis","volume":"122","author":"Zhang","year":"2009","journal-title":"Immunol. Lett."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816301539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572816301539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:27:49Z","timestamp":1759048069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572816301539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":40,"alternative-id":["S0165572816301539"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.07.002","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thymus involvement in myasthenia gravis: Epidemiological and clinical impacts of different self-tolerance breakdown mechanisms","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2016.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}